High Quality HELIOS

Manufactured by Dragon Pharma, Helios is an injectable solution available for purchase in the USA, contained in a 10ml vial at a concentration of 5.8 mg/ml. This product combines the potent fat-burning effects of Clenbuterol Hydrochloride and Yohimbine, making it a popular choice among both male and female athletes for combatting stubborn fat deposits.

Helios operates uniquely by targeting and incinerating fat cells, with each milliliter containing 30mcg of Clenbuterol and 5.6mg of Yohimbine. While Clenbuterol is renowned for its body-drying properties, Yohimbine complements its effects, amplifying Clenbuterol’s efficacy significantly.

Given its robust nature, Helios may induce certain side effects, including but not limited to:

• Elevated blood pressure.
• Disrupted sleep patterns.
• Irritability.
• Muscle tremors.
• Nausea and vomiting.
• Seizures.

Although post-cycle therapy is typically unnecessary with Clenbuterol, to mitigate potential side effects, concurrent use with Ketotifen, sodium, and antihistamines is advised. Initiation of Helios should involve consultation with healthcare professionals or trainers to ensure safe usage.

Guidelines for administering the Clen and Yohimbine mix:

• Limit the course duration to two weeks due to its potency.
• Optimal usage is recommended in the morning to harness the energy released from fat burning.
• Utilize an insulin syringe for precise dosing, focusing on targeted fat deposits.
• Begin with a minimal 1ml dosage, monitoring health status for any adverse reactions.
• Gradually increase the dosage, up to 2.5ml for females and 3.5ml for males, twice daily.
• Taper dosages when concluding the course, reducing by 0.5ml daily.
• Courses lasting 7-14 days can be repeated after a two-week interval if desired results are not achieved.

Helios offers distinct advantages in localized fat burning and prevention of new fat accumulation, making it a valuable tool for individuals seeking targeted fat loss.